ClinicalTrials.Veeva

Menu

Effect of Air Cleaner on the Indoor Allergen Sensitized Allergic Rhinitis Patients

Yonsei University logo

Yonsei University

Status

Completed

Conditions

Allergic Rhinitis

Treatments

Device: Mock device of PuriCare
Device: PuriCare (HEPA Air Cleaner)

Study type

Interventional

Funder types

Other

Identifiers

NCT03313453
4-2017-0588

Details and patient eligibility

About

This study aimed to assess the impact of air cleanser on allergic rhinitis patients and indoor air quality. Air cleaners will be installed in the bedrooms and living rooms of the mite allergic rhinitis patients who aged 18-60 years.

Main parameters:

  • Symptom medication score of allergic rhinitis

Supportive parameters:

  • Visual analog scale of allergic rhinitis
  • Quality of life score of allergic rhinitis
  • Indoor air quality measurement
  • Indoor allergen level measurement

Full description

The most important principle in the treatment of allergic diseases is to avoid or reduce exposure to the causative antigen. Causative agents that induce allergic diseases or exacerbate symptoms are classified into indoor and outdoor allergens. House dust mites and pet's hair are typical indoor antigens. Air pollution as well as allergens are important deterioration factors, and environmental management is essential for alleviating symptoms of allergic diseases. Therefore, we are about to evaluate the impact of the air cleaner to the allergic rhinitis patients.

A total of 45 patients will be enrolled in the study and a real air cleaner and a mock-up air cleaner will be randomly installed at ratio of 1: 1 to measure rhinitis symptoms and the changes in indoor air quality after 6 weeks of operation.

Enrollment

44 patients

Sex

All

Ages

19 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults between 19 and 65 years of age
  • Allergy specialist diagnosis of Moderate to severe persistent allergic rhinitis
  • Retrospective Rhinoconjunctivitis total symptom score higher than 7
  • Allergy against house dust mite: Skin prick test, with a more than 3 mm wheal, Serum specific IgE higher than 0.35 kUA/L measured by ImmunoCAP
  • Who can read and write Korean
  • Participants those who voluntarily agreed to this study

Exclusion criteria

  • Allergy against seasonal allergens (tree, grass, weed pollens)
  • Patients with rhinitis due to other causes (drug induced rhinitis or infectious rhinitis etc.)
  • Patients with severe anatomical abnormality that may cause nasal blockage such as nasal septum deviation or nasal polyps
  • Chronic systemic corticosteroids (≥ 3 months continuous use in past 12 months)
  • Participants planning to move or change residence within the study period.
  • Staying away from the home continuously for more than 5 days in the study period.
  • Having air cleaner previously
  • Having indoor smoker
  • If pregnancy test is positive or pregnancy is possible during study period.
  • Any other reason the participants is deemed unsuitable for participation in clinical trials

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

44 participants in 2 patient groups, including a placebo group

Aircleaner group
Experimental group
Description:
PuriCare (HEPA Air Cleaner) in active mode
Treatment:
Device: PuriCare (HEPA Air Cleaner)
Control comparator
Placebo Comparator group
Description:
Mock device of PuriCare in active mode
Treatment:
Device: Mock device of PuriCare

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems